You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
通脹大主線,最強邏輯!
格隆匯 05-23 19:41

大家好,我是牛四,以後可以叫我牛哥,或者四哥!

以後由我來給大家講市場熱點,投資機會啥的,投資每天看我就夠了。

今天講市場,猴痘、知識產權、通脹大主線。

01

市場

先來看看市場。指數繼續反彈,不得不説在外資砸盤全天流出57億左右的情況下,市場該跌不跌,就顯得很強。中位數達到漲幅1.08%,成交額8600億,温和放量仍舊在良性反彈中

值得注意的是,人民幣今日午後盤中突然直線拉昇超300點,隨後有所回落。這説明美元階段強勢,非美貨幣階段羸弱壓制全球資產的態勢得到一定緩和。另外,加上美股週五深V收回,國內市場多頭情緒就更為頑強。

這段時間,外圍因素已不是決定因素,關鍵還要看國內。市場進入方向選擇期。要突破看兩個信號,一是復工復產,整體供應鏈和消費復甦,市場風險偏好提升,這個已經正在兑現中;另外一個,穩增長的效果(寬財政、信貸、融超預期),不大力出奇跡,仍然只能定義這段下跌只是反彈並非反轉

當前更多是修復疫情的悲觀預期,反彈位置看到3月下旬疫情之前的平台,謹慎且樂觀看

(來源同花順,上證指數走勢演示圖)

02

猴痘

來看看週末傳得沸沸揚揚的猴逗概念。猴痘概念成為周未熱議的話題,“會不會成為下一個流行病”也上了熱搜。人類對未知的東西總是恐懼的,尤其當下新冠還在肆虐,不明原因肝炎也找不到原因,現在又出來一個猴痘,確實讓眾人緊張。現在唯一欣慰的是,接種天花疫苗對預防“猴痘”效果約為85%,並沒有説很可怕。

從炒作上來看,猴痘概念基本也就是週五發酵,週末吹,然後週一收割,類似於前面的肝炎以及千金藤素的炒作路徑,熱點沒什麼持續性。

唯一概念比較正宗的之江生物,有實錘了的猴痘檢測產品造勢炒作,走得也很一般。從今天漲停勢頭來看,並沒有引起板塊集體上漲,放量炸板也就成了必然。之江生物反而還沒早盤就拉板的沒有特點產品的優寧維強。

輝瑞特效藥,再到國產特效藥,再到肝炎,到千金藤,再到猴痘,越來越弱,題材炒作又不香了。尤其猴痘概念,別追,就是逗你的...

03

知識產權

受政策利好提振,知識產權概念股爆發,板塊今日表現明顯強於猴痘概念。

中辦、國辦:支持符合科創屬性的數字化文化企業在科創板上市融資。還提出了8項重點任務。把文化數字提升了新的高度。

這裏敲一下黑板,“中辦、國辦”基本上就是最高級別的,可以去查查全稱。裏面提到從數字經濟到文化數字,有政策回暖的味道。這個方向是短線題材發酵地,參與者更多是短線遊資客,手腳慢的同學要謹慎參與,不然還是去送人頭。

04

通脹

這幾天糧食、煤炭和有色(鋁)都反覆活躍。它們的共同特徵就是通脹,通脹是美聯儲貨幣超發的後遺症,在疊加疫情帶來全球供應鏈受影響的情況下,各類資源供需更加緊張。可以説,通脹會是今年最大的主題。

糧食這塊主要是種業刺激。今年糧食問題一直是焦點問題。雖然我們的糧食沒有太大的問題,但是憂患意識在加強。因為現在全球糧食進入緊供應狀態。週末下發農資補貼,是平抑肥料價格上漲的。從最近的盤面看,市場最活躍龍頭,無疑是農發。

煤炭和鋁反覆表現,有時候你沒關注到,他又上去了,趨勢依舊很好。煤炭這邊主要受印度關税下降消息刺激,印度擬將焦煤、焦炭的進口税率由2.5%、5%降至0關税。鋁驅動因素還是週五印尼限制鋁出口的消息的延續。

從糧食到大宗商品,從歐洲到亞洲,都開啟囤貨模式,説明全球的危機意識開始增強。通脹漲價這條線可以持續關注。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account